Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy

• Lena Berchtold,
• Gilbert Zanetta,
• Karine Dahan,
• Fabrice Mihout,
• Julie Peltier,
• Dominique Guerrot,
• Isabelle Brochériou,
• Pierre Ronco,
• Hanna Debiec

Affiliations

Lena Berchtold

Inserm, UMR_S 1155, Paris, France

Gilbert Zanetta

Department of Nephrology, Dijon University Hospital, Dijon, France

Karine Dahan

Department of Nephrology and Dialysis, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France

Fabrice Mihout

Department of Nephrology and Dialysis, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France

Julie Peltier

Department of Renal Intensive Care Unit and Kidney Transplantation, AP-HP, Tenon Hospital, Paris, France

Dominique Guerrot

Department of Nephrology, Rouen University Hospital, Normandie University, Université de Rouen, Inserm U1096, Rouen, France

Isabelle Brochériou

Department of Pathology, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France

Pierre Ronco

Inserm, UMR_S 1155, Paris, France

Hanna Debiec

Inserm, UMR_S 1155, Paris, France